PROF (Profound Medical) Cyclically Adjusted Price-to-FCF: (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PROF Profound Medical Corp PROF
74 GF Score
Price $5.75
GF Value $10.65
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Profound Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Profound Medical  (NAS:PROF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Profound Medical Cyclically Adjusted Price-to-FCF Related Terms


Profound Medical Cyclically Adjusted Price-to-FCF Historical Data

* Premium members only.

The historical data trend for Profound Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical Cyclically Adjusted Price-to-FCF Chart

Profound Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Profound Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PROF vs ABT, SYK, MDT: Cyclically Adjusted Price-to-FCF Comparison

For the Medical Devices subindustry, Profound Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Profound Medical's Cyclically Adjusted Price-to-FCF falls into.


PROF
74GF Score
Profound Medical Corp PROF
Cyclically Adjusted Price-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profound Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Profound Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Profound Medical's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.309/133.5265*133.5265
=-0.309

Current CPI (Jun. 2026) = 133.5265.

Profound Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.629 101.765 -0.825
201612 -0.715 101.449 -0.941
201703 -0.532 102.634 -0.692
201706 -0.568 103.029 -0.736
201709 -0.394 103.345 -0.509
201712 -0.480 103.345 -0.620
201803 -0.380 105.004 -0.483
201806 -0.384 105.557 -0.486
201809 -0.331 105.636 -0.418
201812 -0.296 105.399 -0.375
201903 -0.224 106.979 -0.280
201906 -0.433 107.690 -0.537
201909 -0.239 107.611 -0.297
201912 -0.461 107.769 -0.571
202003 -0.369 107.927 -0.457
202006 -0.212 108.401 -0.261
202009 -0.252 108.164 -0.311
202012 0.000 108.559 0.000
202103 -0.311 110.298 -0.376
202106 -0.305 111.720 -0.365
202109 -0.233 112.905 -0.276
202112 -0.241 113.774 -0.283
202203 -0.378 117.646 -0.429
202206 -0.265 120.806 -0.293
202209 -0.262 120.648 -0.290
202212 -0.282 120.964 -0.311
202303 -0.281 122.702 -0.306
202306 -0.226 124.203 -0.243
202309 -0.211 125.230 -0.225
202312 -0.340 125.072 -0.363
202403 -0.210 126.258 -0.222
202406 -0.228 127.522 -0.239
202409 -0.289 127.285 -0.303
202412 -0.202 127.364 -0.212
202503 -0.276 129.181 -0.285
202506 -0.470 129.892 -0.483
202509 -0.323 130.287 -0.331
202512 -0.206 130.366 -0.211
202603 -0.236 132.262 -0.238
202606 -0.309 133.527 -0.309

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Profound Medical (PROF) Overvalued in 2026?

Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued. The current stock price of $5.75 is trading 46% below its estimated GF Value™ of $10.65. GuruFocus considers Profound Medical to be Possible Value Trap.

Key valuation signals for PROF:

  • Cyclically Adjusted Price-to-FCF:
  • GF Value™: $10.65 vs. price of $5.75 (46% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profound Medical Business Description

Other Exchanges PRN:Canada
Address 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
74GF Score

Get the complete analysis for PROF

Cyclically Adjusted Price-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.75
Price
$10.65
GF Value